Replies to post #577347 on NorthWest Biotherapeutics Inc (NWBO)

[pqr]

Flex- in Harrington v CIBC, a judge sitting in the same court as the nwbo case denied those defendants’ argument that trading for customer accounts could relieve those defendants from possible liability for the spoofing claims against them at the MTD 12.b.6 stage: That defendants trade for customer as well as their own accounts “does not undercut the … numerous allegations that Defendants designed and operated the algorithms that spoofed.” 2/9/22 Opinion and Order, Slip op at 10.

Also I am unaware of caselaw excusing unlawful conduct on the basis that, “somebody paid me to break the law.” Further I am skeptical that our defendants
can produce many customer orders that basically direct defendants to engage in order entry and trading activities that constitute spoofing. Any such customers shown in CDEL and other defendants’ discovery disclosures who DID so direct their brokers might conveniently be referred to in the future by another name: “Co-Defendants.”

[Roman516]

The plaintiff has rights!
In my business classes regarding law school cases, when the plaintiff is the little guy,
and has stated that they have proof of the actions which the defendants invoked, look out.
In many cases studies, the Judge takes these cases seriously. I hope this case goes to trial and the jury comes to a unanimous conclusion, of guilty, IMPO.
Gee, the little guy is working on a cure for both nGBM and rGBM brain cancer, plus the potential for curing multiple solid tumor cancers, and the big guy's step on the little guy.
The truth of the matter is that NWBO is the little guy, and the big guys are in big trouble, IMPO.